Tagliabue E - Search Results

1

What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.

Pizzamiglio S, Cosentino G, Ciniselli CM, De Cecco L, Cataldo A, Plantamura I, Triulzi T, El-Abed S, Wang Y, Bajji M, Nuciforo P, Huober J, Ellard SL, Rimm DL, Gombos A, Daidone MG, Verderio P, Tagliabue E, Di Cosimo S, Iorio MV. Pizzamiglio S, et al. Among authors: tagliabue e. Cancer Med. 2022 Jan;11(2):332-339. doi: 10.1002/cam4.4449. Epub 2021 Dec 17. Cancer Med. 2022. PMID: 34921525 Free PMC article. Clinical Trial.

2

Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients.

Porro G, Ménard S, Tagliabue E, Orefice S, Salvadori B, Squicciarini P, Andreola S, Rilke F, Colnaghi MI. Porro G, et al. Among authors: tagliabue e. Cancer. 1988 Jun 15;61(12):2407-11. doi: 10.1002/1097-0142(19880615)61:12<2407::aid-cncr2820611202>3.0.co;2-g. Cancer. 1988. PMID: 3284635

3

Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features.

Ménard S, Squicciarini P, Luini A, Sacchini V, Rovini D, Tagliabue E, Veronesi P, Salvadori B, Veronesi U, Colnaghi MI. Ménard S, et al. Among authors: tagliabue e. Br J Cancer. 1994 Jun;69(6):1126-9. doi: 10.1038/bjc.1994.221. Br J Cancer. 1994. PMID: 7911032 Free PMC article.

4

Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cells.

Tagliabue E, Ardini E, Pellegrini R, Campiglio M, Bufalino R, Jeschke M, Groner B, Colnaghi MI, Ménard S. Tagliabue E, et al. Br J Cancer. 1996 Nov;74(9):1427-33. doi: 10.1038/bjc.1996.560. Br J Cancer. 1996. PMID: 8912540 Free PMC article.

5

Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells.

Tagliabue E, Ghirelli C, Squicciarini P, Aiello P, Colnaghi MI, Ménard S. Tagliabue E, et al. Clin Cancer Res. 1998 Feb;4(2):407-10. Clin Cancer Res. 1998. PMID: 9516929

6

Role of HER2 gene overexpression in breast carcinoma.

Ménard S, Tagliabue E, Campiglio M, Pupa SM. Ménard S, et al. Among authors: tagliabue e. J Cell Physiol. 2000 Feb;182(2):150-62. doi: 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E. J Cell Physiol. 2000. PMID: 10623878 Review.

7

HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer.

Ménard S, Casalini P, Campiglio M, Pupa S, Agresti R, Tagliabue E. Ménard S, et al. Among authors: tagliabue e. Ann Oncol. 2001;12 Suppl 1:S15-9. doi: 10.1093/annonc/12.suppl_1.s15. Ann Oncol. 2001. PMID: 11521715 Free article. Review.

8

HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors.

Ménard S, Balsari A, Casalini P, Tagliabue E, Campiglio M, Bufalino R, Cascinelli N. Ménard S, et al. Among authors: tagliabue e. Clin Cancer Res. 2002 Feb;8(2):520-5. Clin Cancer Res. 2002. PMID: 11839672

9

Role of HER2 in wound-induced breast carcinoma proliferation.

Tagliabue E, Agresti R, Carcangiu ML, Ghirelli C, Morelli D, Campiglio M, Martel M, Giovanazzi R, Greco M, Balsari A, Ménard S. Tagliabue E, et al. Lancet. 2003 Aug 16;362(9383):527-33. doi: 10.1016/S0140-6736(03)14112-8. Lancet. 2003. PMID: 12932384

10

Biologic and therapeutic role of HER2 in cancer.

Ménard S, Pupa SM, Campiglio M, Tagliabue E. Ménard S, et al. Among authors: tagliabue e. Oncogene. 2003 Sep 29;22(42):6570-8. doi: 10.1038/sj.onc.1206779. Oncogene. 2003. PMID: 14528282 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

342 results

Search Page